M-0002

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 529429

CAS#: 285559-03-7 (M-0002 HCl)

Description: M-0002, also known as RWJ-351647 and SPD-556, is a vasopressin V2 receptor antagonist potentially for the treatment of ascites.


Chemical Structure

img
M-0002
CAS# 285559-03-7 (M-0002 HCl)

Theoretical Analysis

MedKoo Cat#: 529429
Name: M-0002
CAS#: 285559-03-7 (M-0002 HCl)
Chemical Formula: C32H29Cl2N3O3
Exact Mass: 0.00
Molecular Weight: 574.500
Elemental Analysis: C, 66.90; H, 5.09; Cl, 12.34; N, 7.31; O, 8.35

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 285571-93-9 (M-0002 free base)  

Synonym: M-0002; RWJ-351647; SPD-556; M0002; RWJ351647; SPD556; M 0002; RWJ 351647; SPD 556

IUPAC/Chemical Name: (S)-N-(3-chloro-4-(3,4,6,11,12,12a-hexahydro-1H-benzo[e][1,4]oxazino[4,3-a][1,4]diazepine-11-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamide hydrochloride

InChi Key: NTTUAEGHFUAPMK-UQIIZPHYSA-N

InChi Code: InChI=1S/C32H28ClN3O3.ClH/c33-29-18-24(34-31(37)27-12-6-5-11-26(27)22-8-2-1-3-9-22)14-15-28(29)32(38)36-20-25-21-39-17-16-35(25)19-23-10-4-7-13-30(23)36;/h1-15,18,25H,16-17,19-21H2,(H,34,37);1H/t25-;/m0./s1

SMILES Code: O=C(C1=CC=CC=C1C2=CC=CC=C2)NC3=CC=C(C(N4C[C@](COCC5)([H])N5CC6=CC=CC=C64)=O)C(Cl)=C3.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 574.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Thuluvath PJ, Maheshwari A, Wong F, Yoo HW, Schrier RW, Parikh C, Steare S, Korula J. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study. Aliment Pharmacol Ther. 2006 Sep 15;24(6):973-82. PubMed PMID: 16948809.

2: Gunnet JW, Matthews JM, Maryanoff BE, de Garavilla L, Andrade-Gordon P, Damiano B, Hageman W, Look R, Stahle P, Streeter AJ, Wines PG, Demarest KT. Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonist. Clin Exp Pharmacol Physiol. 2006 Apr;33(4):320-6. PubMed PMID: 16620295.

3: Ros J, Fernández-Varo G, Muñoz-Luque J, Arroyo V, Rodés J, Gunnet JW, Demarest KT, Jiménez W. Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention. Br J Pharmacol. 2005 Nov;146(5):654-61. PubMed PMID: 16113688; PubMed Central PMCID: PMC1751206.

4: Costello-Boerrigter LC, Boerrigter G, Burnett JC Jr. Pharmacology of vasopressin antagonists. Heart Fail Rev. 2009 Jun;14(2):75-82. doi: 10.1007/s10741-008-9108-8. Review. PubMed PMID: 18766438.